DICE Therapeutics Inc (DICE) Actualités

Lilly Completes Acquisition of DICE Therapeutics

Lilly Completes Acquisition of DICE Therapeutics PR Newswire INDIANAPOLIS, Aug. 9, 2023 INDIANAPOLIS, Aug. 9...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form SC 14D9/A - Solicitation, recommendation statements: [Amend]

Lilly Announces Extension of Tender Offer to Acquire DICE

Lilly Announces Extension of Tender Offer to Acquire DICE PR Newswire INDIANAPOLIS, July 25, 2023...

Form SC 14D9/A - Solicitation, recommendation statements: [Amend]

Form SC 14D9 - Solicitation, recommendation statements

Statement of Changes in Beneficial Ownership (4)

FORM 4 ☒ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b...

Amended Statement of Beneficial Ownership (sc 13d/a)

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     SCHEDULE 13D Under the...

Amended Statement of Beneficial Ownership (sc 13d/a)

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     SCHEDULE 13D UNDER THE...

Amended Statement of Beneficial Ownership (sc 13d/a)

        SECURITIES AND EXCHANGE COMMISSION     Washington, D.C. 20549...

Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     SCHEDULE 14D-9 (Rule 14d-101...

Written Communication Relating to an Issuer or Third Party (sc To-c)

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     SCHEDULE TO Tender Offer...

Current Report Filing (8-k)

false 0001645569 0001645569 2023-06-18 2023-06-18     UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549  ...

Lilly to Acquire DICE Therapeutics to Advance Innovation in Immunology

Lilly to Acquire DICE Therapeutics to Advance Innovation in Immunology PR Newswire INDIANAPOLIS and SOUTH SAN...

DICE Therapeutics to Host R&D Investor Event on Tuesday, June 20, 2023

SOUTH SAN FRANCISCO, Calif., June 13, 2023 (GLOBE NEWSWIRE) -- DICE Therapeutics, Inc. (Nasdaq: DICE) (DICE...